Gregory P Bisson Selected Research

Gregory P Bisson Research Topics

Disease

30	Tuberculosis (Tuberculoses) 01/2021 - 10/2008
6	Infections 10/2017 - 04/2011
5	Pulmonary Tuberculosis 10/2020 - 12/2013
5	Inflammation (Inflammations) 01/2020 - 10/2012
4	Immune Reconstitution Inflammatory Syndrome 10/2020 - 04/2015
4	HIV Infections (HIV Infection) 01/2020 - 10/2012
4	Cryptococcal Meningitis 01/2019 - 10/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 05/2008
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 06/2014
2	Meningeal Tuberculosis (Tuberculous Meningitis) 03/2011 - 09/2010
1	Pneumonia (Pneumonitis) 01/2020
1	Lung Injury 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Drug-Related Side Effects and Adverse Reactions 04/2019
1	Hepatitis 01/2018
1	Lymphadenopathy 10/2017
1	Coinfection 05/2017
1	Central Nervous System Infections (Central Nervous System Infection) 06/2015
1	Epilepsy (Aura) 06/2015
1	AIDS Dementia Complex 06/2015
1	Necrosis 04/2015
1	Latent Tuberculosis 10/2013
1	Lung Diseases (Lung Disease) 10/2013
1	Insulin Resistance 10/2012
1	Anemia 01/2011
1	Viremia 11/2005

Drug/Important Bio-Agent (IBA)

7	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 09/2010
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
3	Pyrazinamide FDA LinkGeneric 03/2018 - 04/2011
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2016 - 12/2012
3	RNA (Ribonucleic Acid)IBA 12/2013 - 11/2005
2	InflammasomesIBA 01/2020 - 05/2018
2	AcidsIBA 01/2020 - 10/2013
2	liposomal amphotericin B FDA Link 01/2019 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2016 - 04/2015
2	Tuberculin (PPD)IBA 10/2013 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2012 - 04/2011
1	lipoarabinomannan (LAM)IBA 01/2021
1	AntigensIBA 01/2021
1	Antitubercular AgentsIBA 01/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2019
1	efavirenz (Sustiva)FDA Link 04/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2019
1	Peptide Hydrolases (Proteases)FDA Link 03/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	bedaquiline (R207910)IBA 01/2018
1	FluoroquinolonesIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Serum AlbuminIBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Fluconazole (Zonal)FDA LinkGeneric 06/2015
1	InterleukinsIBA 04/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2015
1	RifamycinsIBA 12/2012
1	prothrombin complex concentrates (PPSB)IBA 12/2012
1	Erythromycin (Erycette)FDA LinkGeneric 12/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2012
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 10/2012
1	Vitamin D FDA LinkGeneric 10/2012
1	Reverse Transcriptase InhibitorsIBA 05/2008
1	NucleosidesIBA 05/2008

Therapy/Procedure

20	Therapeutics 01/2021 - 01/2011
7	Art Therapy 12/2020 - 04/2013
2	Highly Active Antiretroviral Therapy (HAART) 06/2015 - 10/2008
1	Aftercare (After-Treatment) 01/2021
1	Duration of Therapy 01/2018
1	Glycemic Control 10/2012